Elsamany SA, Elemam O, Hassanin F, Algahami A, Alghanmi H, El naghi KAEA. Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients. World J Oncol [Internet]. 2025 Jan. 1 [cited 2026 Feb. 1];16(5):502-8. Available from: https://wjon.elmerpub.com/wjon/article/view/2546